Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 20,887 followers.

RT @ingentium_ms: Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials. https://t.co/oaUF3…

Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials. https://t.co/oaUF3TYdj2 https://t.co/wnbiKJ0F4q

RT @AaronBosterMD: Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials - PubMed https://t…

RT @AaronBosterMD: Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials - PubMed https://t…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.